Showing 971-980 of 1688 results for "".
- Establishment Labs Surpasses 3 Million Motiva Deviceshttps://modernaesthetics.com/news/establishment-labs-surpasses-3-million-motiva-devices/2473383/Establishment Labs Holdings announced that it has surpassed 3 million Motiva devices in market. The devices have been delivered to plastic and reconstructive surgeons since 2010 and are available in more than 85 countries. “Since its founding, Establishment Labs has been guid
- EON Robotic Body Contouring Device Gains Additional FDA Clearance for Back and Thighshttps://modernaesthetics.com/news/eon-robotic-body-contouring-device-gains-additional-fda-clearance-for-back-and-thighs/2473380/EON Smarter Body Contouring has received FDA clearance for the back and thighs—the third FDA clearance for EON. The device was previously FDA-cleared for clinical providers to treat patients' full abdomen and flanks. Parent company Dominion Aesthetic Technologies describe
- The Cellulite Wars Heat Up: Sentient Sculpt Enters U.S. Markethttps://modernaesthetics.com/news/the-cellulite-wars-heat-up-sentient-sculpt-enters-us-market/2473377/Sentient, LLC is bringing Sentient Sculpt to the U.S. market. Sentient Sculpt is a non-invasive professional electromagnetic wave and microwave treatment for cellulite reduction. Unlike other products on the market that are absorbed in the skin or medical devices that incise tissue, Sen
- Botox Cosmetic, IFundWomen Join Forces to Help Close the Confidence Gap for Women Entrepreneurshttps://modernaesthetics.com/news/botox-cosmetic-ifundwomen-join-forces-to-help-close-the-confidence-gap-for-women-entrepreneurs/2473375/In honor of International Women's Day, Allergan Aesthetics,’ an AbbVie company, is partnering with IFundWomen, the funding marketplace for women-owned businesses, on a grant program. Women entrepreneurs can apply for the opportunity to receive one of 20 grants worth
- ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals in Korea and Hyaluronic Acid (HA) Dermal Fillers in Brazilhttps://modernaesthetics.com/news/exocobio-obtains-gmp-licenses-for-exosome-biopharmaceuticals-in-korea-and-hyaluronic-acid-ha-dermal-fillers-in-brazil/2473370/ExoCoBio announced that it has obtained the "Certificate of Advanced Biopharmaceutical Manufacturing" from the Ministry of Food and Drug Safety in Korea, and the "HA Filler GMP Certification" from the Brazilian Food and Drug Health Monitoring Agency (ANVISA). Accordi
- Neauvia Granted CE Marking Under the E.U.’s New MDR for Facial Dermal Filler Linehttps://modernaesthetics.com/news/neauvia-granted-ce-marking-under-the-eus-new-mdr-for-facial-dermal-filler-line/2473362/Neauvia scored CE marking under the European Union’s new MDR (Medical Device Regulation) for its range of facial dermal fillers products, making it the first medical aesthetics business to receive such certification in Europe. The new regulation aims to create ‘a robus
- Industry Vet Crystal Muilenburg Joins Elevai’s Board of Directorshttps://modernaesthetics.com/news/industry-vet-crystal-muilenburg-joins-elevais-board-of-directors/2473357/Crystal Muilenburg is the newest member of Elevai’s Board of Directors. A former Evolus and Allergan executive, Muilenburg will play a key role in supporting the Elevai management team as it commercializes Elevai’s flagship exosome product line while driving t
- Study: Jeuveau “Extra-Strength” Dose Shows Lasting Resultshttps://modernaesthetics.com/news/evolus-to-present-phase-2-interim-data-from-jeuveau-extra-strength-dose-for-extended-duration-study-at-2023-imcas-world-congress/2473346/Evolus' Jeuveau Extra-Strength achieved one-point improvement on the Glabellar Lines Scale with the duration of effect lasting 26 weeks, representing a prolonged 6-month performance, the Company reports. The extra-strength glabellar line study is a multicenter, double
- Endo Pulls Qwo from Markethttps://modernaesthetics.com/news/endo-pulls-qwo-from-market/2473339/Endo International plc is ceasing the production and sale of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes) in light of market concerns about the extent and variability of bruising following initial treatment as well as the potential for prolonged skin discoloratio
- Galderma Celebrates Self-Expression at Miami Art Week 2022https://modernaesthetics.com/news/galderma-celebrates-self-expression-at-miami-art-week-2022/2473335/Galderma is the exclusive aesthetic injectables sponsor of the 21st annual SCOPE Miami Beach 2022 art show. Galderma will be highlighting its aesthetics portfolio – Restylane, Dysport (abobotulinumtoxinA) and Sculptra – and hosting a variety of